12:00 AM
Dec 04, 2000
 |  BC Week In Review  |  Company News  |  Deals

Genesis Bioventures, Prion Developmental Laboratories Inc. deal

BILB made a second $1 million investment in Prion, which is developing diagnostics to detect prion-based diseases such...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >